Most catalog peptides are not fermented like insulin. They are assembled one amino acid at a time on a plastic bead, then cut off, purified, and freeze-dried into the white cake in the vial. Robert Bruce Merrifield published that method in 1963, and it won the 1984 Nobel Prize in Chemistry.

TL;DR

  • Solid-phase peptide synthesis (SPPS) grows the chain from the C-terminus while it is stuck to a resin, so leftover reagents wash away (Merrifield, 1963; Bachem).
  • Each cycle is four moves: take off the temporary cap, wash, couple the next protected amino acid, wash (Bachem).
  • Fmoc/tBu chemistry is the modern default. Therapeutic peptides are now made by Fmoc SPPS at multiton scale (Behrendt et al., 2016).
  • The crude cut is a mixture. Deletion sequences, truncated chains, leftover protecting groups. Reversed-phase HPLC, then lyophilization, is how it becomes powder (Bachem).
  • FDA calls a chain of 40 or fewer amino acids a peptide, not a protein. That is a regulatory size cut, not a quality stamp on a research vial (21 CFR 600.3).

Why is a peptide built on a bead?

Solution-phase synthesis used to mean isolating every intermediate. Merrifield’s move was to covalently attach the first amino acid to an insoluble polystyrene resin, then add the rest one by one. Excess reagents and by-products leave by filtration (Merrifield, 1963).

The 1963 demonstration was a tetrapeptide, leucyl-alanyl-glycyl-valine. The Nobel committee later credited him “for his development of methodology for chemical synthesis on a solid matrix” (Nobel Prize, 1984).

Bachem, a major manufacturer, still describes SPPS the same way. The peptide is anchored by its C-terminus. Each added residue is a cycle: cleave the N-alpha protecting group, wash, couple, wash (Bachem SPPS).

For what a peptide is chemically, start with Peptides 101 or the beginner definition. This page is the factory floor.

Is this the same as making insulin in cells?

No. Recombinant proteins are expressed in microbes or mammalian cells. SPPS is organic chemistry. That is why analog peptides can include D-amino acids, lipid tails, and non-natural residues that a ribosome will not install.

More than 80 peptide drugs have reached the market since insulin, for diabetes, cancer, osteoporosis, multiple sclerosis, HIV, and chronic pain (Muttenthaler et al., 2021). Many of those later drugs exist because chemists could edit the sequence on the bench.

FDA draws a size line for regulation. A “protein” is an alpha amino acid polymer with a defined sequence greater than 40 amino acids. Chains of 40 or fewer sit outside that definition (21 CFR 600.3(h)(6); Federal Register, 2020).

A research vial is still not a licensed product. Synthesis method does not confer an approved drug application.

Boc or Fmoc: what is on the modern instrument?

Two protecting-group schemes dominate SPPS. Boc/benzyl was the original. Fmoc/tert-butyl (Fmoc/tBu) is the combination that most labs and plants run now (Bachem SPPS).

Fmoc is 9-fluorenylmethoxycarbonyl, the temporary cap on the amino nitrogen. It comes off with piperidine. Side chains stay protected with tert-butyl-type groups until the final acid cleavage. Bachem notes that Fmoc deprotection should be done in a hood because of piperidine exposure (Bachem SPPS).

Behrendt, White, and Offer were blunt in 2016. Fmoc SPPS is the method of choice. High-quality Fmoc building blocks got cheap because therapeutic peptides are produced at multiton scale with that chemistry (Behrendt et al., 2016).

Boc chemistry still exists. It uses trifluoroacetic acid (TFA) to take off the Boc group at every cycle, and a harsher final cleavage. Bachem still teaches both. For a beginner reading a catalog, Fmoc is the working assumption unless the COA says otherwise.

What is in the crude peptide before HPLC?

The chain does not come off the resin clean. After cleavage, Bachem lists the usual companions: deletion peptides (a residue that failed to couple), truncated peptides, incompletely deprotected peptides, modified peptides, residual reagents, and by-products from cleaved protecting groups (Bachem purification).

That is why a certificate of analysis talks about HPLC purity and mass spec identity. Purity is how much of the peak is the target sequence. Identity is whether that peak is the right molecule.

Step What actually happens Beginner takeaway
Resin loading C-terminus of the first amino acid is attached to polystyrene beads (Bachem) The bead is a handle, not part of the peptide sequence.
Cycle Deprotect, wash, couple, wash, repeated down the sequence (Bachem) Missed couplings become deletion impurities.
Cleavage Acid, often TFA in Fmoc work, cuts the peptide off the resin (Bachem) Crude material is a mixture, not a finished drug.
RP-HPLC C18 silica, water to acetonitrile with 0.1% TFA, UV at 210 to 220 nm (Bachem) This is the cleanup.
Lyophilization The pooled HPLC fraction is freeze-dried to a white powder (Bachem) Dry cake is the shipping form. See storage.

Basic peptides come off as TFA salts. The N-terminus, arginine, lysine, and histidine bind TFA. Bachem says those salts are not removed during ordinary purification (Bachem purification). Net peptide content on a COA is why a 5 mg label is not 5 mg of free peptide.

How does the powder get mixed?

The white cake is lyophilized. Water was removed on purpose so hydrolysis slows down. Mixing it is a separate step, covered in the reconstitution guide and the calculator.

A licensed pen and a research vial can share a synthesis family and still be different objects. One has a label, an in-use date, and a manufacturer. The other has a COA, if the vendor published one.

Compare listed products on the price index. Find clinics and pharmacies in the provider directory.

People who teach the chemistry rather than the rumor mill are on the experts page.

Bottom line Peptides are made by chemistry, usually Fmoc solid-phase synthesis, then HPLC and freeze-drying. The method is why analogs exist. It is not a substitute for a licensed product or a COA.

Educational only. Not medical advice.